Decongestants
Decongestants - Related Videos
01:27
Upper Respiratory Drugs: Decongestants
0 Views •
2024
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion. Most decongestants are readily available over-the-counter in various...
04:46
A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation
0 Views •
2011
We describe a technique to maintain oxygenation and ventilation using an endotracheal tube inserted nasally to the level of the naso-pharynx while sealing the mouth and nares for successful positive pressure ventilation.
13:19
Compound Administration III
0 Views •
2015
Source: Kay Stewart, RVT, RLATG, CMAR; Valerie A. Schroeder, RVT, RLATG. University of Notre Dame, IN There are many commonly used routes for compound administration in laboratory mice and rats. However, certain protocols may require the use of less commonly used routes, including intradermal, intranasal, and intracranial injections. Specialized training is essential for these procedures to be performed successfully. Justification for these routes may need to be provided to gain Institutional...
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
0 Views •
Cited by 17 •
2011
We describe guidelines to perform a safe and efficient elective fiberoptic intubation in pediatric patients while maintaining spontaneous ventilation.
FAQs
The key effect is vascular rather than a simple reduction in mucus. Stimulating adrenergic receptors in nasal blood vessels causes vasoconstriction, which lowers local blood flow and reduces edema in inflamed mucous membranes. As the swollen tissue occupies less space, the nasal passage becomes less obstructed. This mechanism explains why decongestants matter in respiratory pharmacology.
Route changes the extent of drug exposure. Topical formulations act at the nasal site, whereas oral agents produce systemic effects beyond the nasal mucosa. This distinction matters because oral treatment may influence cardiovascular measures such as blood pressure or heart rate, while topical treatment raises particular concern when used for too long. Route therefore affects both expected action and safety considerations.
Repeated or prolonged topical exposure can produce rebound congestion, in which obstruction returns or worsens after the initial benefit. This limitation is tied to duration rather than simply to the goal of relieving symptoms. Consequently, topical therapy must be evaluated with attention to how long it is used, because extended exposure can undermine the desired nasal outcome.
Decongestants may be considered when obstruction accompanies colds, allergic rhinitis, or sinus inflammation. Their pharmacologic role is symptom relief: reducing mucosal swelling can make breathing through the nose easier, but the expected benefit depends on route, dose, and duration. Thus, the same broad symptom may require different treatment considerations depending on the condition and the chosen approach.
Selection begins with the intended site and scope of action: a topical product provides local nasal action, whereas an oral product brings systemic exposure. The choice must then account for dose and duration, since these variables influence the balance between symptom benefit and risk. This framework helps connect pharmacologic mechanism with practical patient-care decisions.
Patient-care decisions should include both local and systemic safety concerns. With topical products, prolonged use can lead to rebound congestion. With systemic treatment, effects on blood pressure or heart rate may become relevant. These distinct outcomes show why route and duration should not be treated as interchangeable, even when products are chosen to relieve similar respiratory obstruction.